GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1976 - 2000** of **4050** in total

« First

‹ Prev

…

76

77

78

79

80

81

82

83

84

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G41200QS	101
IgM	Patient 3	4	mild	G41200QS	87
IgA	Patient 4	12	mild	G41200QS	367
IgG	Patient 4	12	mild	G41200QS	77
IgM	Patient 4	12	mild	G41200QS	153
IgA	Patient 1	10	moderate	G42346AP	335
IgA	Patient 1	22	moderate	G42346AP	436
IgA	Patient 1	6	moderate	G42346AP	372
IgG	Patient 1	10	moderate	G42346AP	23
IgG	Patient 1	22	moderate	G42346AP	39
IgM	Patient 1	10	moderate	G42346AP	41
IgM	Patient 1	22	moderate	G42346AP	256
IgA	Patient 2	15	mild	G42346AP	394
IgA	Patient 2	24	mild	G42346AP	416
IgG	Patient 2	15	mild	G42346AP	51
IgG	Patient 2	24	mild	G42346AP	58
IgM	Patient 2	15	mild	G42346AP	276
IgM	Patient 2	24	mild	G42346AP	351
IgG	Patient 1	6	moderate	G42346AP	24
IgM	Patient 1	6	moderate	G42346AP	30
IgA	Patient 2	3	mild	G42346AP	360
IgG	Patient 2	3	mild	G42346AP	51
IgM	Patient 2	3	mild	G42346AP	235
IgA	Patient 3	-180	mild	G42346AP	3686
IgA	Patient 3	11	mild	G42346AP	4133